CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 124 filers reported holding CYTOKINETICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,754,352 | -23.7% | 253,864 | -1.3% | 0.22% | -24.3% |
Q1 2024 | $18,029,978 | -16.4% | 257,167 | -0.5% | 0.28% | -21.8% |
Q4 2023 | $21,570,309 | +182.3% | 258,358 | -0.4% | 0.36% | +155.6% |
Q3 2023 | $7,639,832 | -13.4% | 259,329 | -4.1% | 0.14% | -7.2% |
Q2 2023 | $8,819,176 | -10.5% | 270,361 | -3.4% | 0.15% | -24.3% |
Q1 2023 | $9,853,411 | -24.5% | 280,006 | -1.7% | 0.20% | -28.9% |
Q4 2022 | $13,047,016 | -7.1% | 284,745 | -1.8% | 0.28% | -11.8% |
Q3 2022 | $14,043,000 | +19.1% | 289,851 | -3.4% | 0.32% | +25.3% |
Q2 2022 | $11,793,000 | +6.3% | 300,146 | -0.4% | 0.26% | +31.1% |
Q1 2022 | $11,097,000 | -22.8% | 301,464 | -4.4% | 0.20% | -21.0% |
Q4 2021 | $14,366,000 | +26.7% | 315,192 | -0.6% | 0.25% | +18.7% |
Q3 2021 | $11,337,000 | +73.9% | 317,215 | -3.7% | 0.21% | +77.1% |
Q2 2021 | $6,519,000 | -13.6% | 329,395 | +1.6% | 0.12% | -18.1% |
Q1 2021 | $7,543,000 | +0.9% | 324,299 | -9.8% | 0.14% | -5.3% |
Q4 2020 | $7,475,000 | -10.1% | 359,724 | -6.3% | 0.15% | -22.8% |
Q3 2020 | $8,315,000 | -11.6% | 384,061 | -3.8% | 0.20% | -15.1% |
Q2 2020 | $9,409,000 | +98.1% | 399,178 | -0.9% | 0.23% | +61.1% |
Q1 2020 | $4,750,000 | -5.6% | 402,893 | -15.1% | 0.14% | +30.9% |
Q4 2019 | $5,034,000 | -14.9% | 474,476 | -8.7% | 0.11% | -20.9% |
Q3 2019 | $5,913,000 | -3.9% | 519,571 | -5.0% | 0.14% | -3.5% |
Q2 2019 | $6,150,000 | +26.6% | 546,646 | -9.0% | 0.14% | +30.9% |
Q1 2019 | $4,857,000 | +29.7% | 600,388 | +1.3% | 0.11% | +13.4% |
Q4 2018 | $3,746,000 | -41.4% | 592,778 | -8.7% | 0.10% | -27.1% |
Q3 2018 | $6,396,000 | +1.6% | 649,291 | -14.4% | 0.13% | +3.1% |
Q2 2018 | $6,294,000 | -1.6% | 758,325 | -14.6% | 0.13% | +3.2% |
Q1 2018 | $6,397,000 | -10.6% | 888,415 | +1.2% | 0.12% | -8.8% |
Q4 2017 | $7,152,000 | -51.1% | 877,575 | -13.0% | 0.14% | -49.3% |
Q3 2017 | $14,628,000 | – | 1,008,805 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |